Cargando…

Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey

Detalles Bibliográficos
Autores principales: Klonoff, David, Nayberg, Irina, Erbstein, Frank, Cali, Anna, Brulle-Wohlhueter, Claire, Haak, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525641/
https://www.ncbi.nlm.nih.gov/pubmed/26002837
http://dx.doi.org/10.1177/1932296815586219
_version_ 1782384344240750592
author Klonoff, David
Nayberg, Irina
Erbstein, Frank
Cali, Anna
Brulle-Wohlhueter, Claire
Haak, Thomas
author_facet Klonoff, David
Nayberg, Irina
Erbstein, Frank
Cali, Anna
Brulle-Wohlhueter, Claire
Haak, Thomas
author_sort Klonoff, David
collection PubMed
description
format Online
Article
Text
id pubmed-4525641
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-45256412016-05-22 Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey Klonoff, David Nayberg, Irina Erbstein, Frank Cali, Anna Brulle-Wohlhueter, Claire Haak, Thomas J Diabetes Sci Technol Letters to the Editor SAGE Publications 2015-05-22 /pmc/articles/PMC4525641/ /pubmed/26002837 http://dx.doi.org/10.1177/1932296815586219 Text en © 2015 Diabetes Technology Society http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letters to the Editor
Klonoff, David
Nayberg, Irina
Erbstein, Frank
Cali, Anna
Brulle-Wohlhueter, Claire
Haak, Thomas
Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
title Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
title_full Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
title_fullStr Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
title_full_unstemmed Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
title_short Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey
title_sort usability of the gla-300 injection device compared with three other commercialized disposable insulin pens: results of an interview-based survey
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525641/
https://www.ncbi.nlm.nih.gov/pubmed/26002837
http://dx.doi.org/10.1177/1932296815586219
work_keys_str_mv AT klonoffdavid usabilityofthegla300injectiondevicecomparedwiththreeothercommercializeddisposableinsulinpensresultsofaninterviewbasedsurvey
AT naybergirina usabilityofthegla300injectiondevicecomparedwiththreeothercommercializeddisposableinsulinpensresultsofaninterviewbasedsurvey
AT erbsteinfrank usabilityofthegla300injectiondevicecomparedwiththreeothercommercializeddisposableinsulinpensresultsofaninterviewbasedsurvey
AT calianna usabilityofthegla300injectiondevicecomparedwiththreeothercommercializeddisposableinsulinpensresultsofaninterviewbasedsurvey
AT brullewohlhueterclaire usabilityofthegla300injectiondevicecomparedwiththreeothercommercializeddisposableinsulinpensresultsofaninterviewbasedsurvey
AT haakthomas usabilityofthegla300injectiondevicecomparedwiththreeothercommercializeddisposableinsulinpensresultsofaninterviewbasedsurvey